677 related articles for article (PubMed ID: 27017072)
1. Transcranial Magnetic Stimulation of Left Dorsolateral Prefrontal Cortex Induces Brain Morphological Changes in Regions Associated with a Treatment Resistant Major Depressive Episode: An Exploratory Analysis.
Lan MJ; Chhetry BT; Liston C; Mann JJ; Dubin M
Brain Stimul; 2016; 9(4):577-83. PubMed ID: 27017072
[TBL] [Abstract][Full Text] [Related]
2. Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression.
Kito S; Fujita K; Koga Y
Neuropsychobiology; 2008; 58(1):29-36. PubMed ID: 18781088
[TBL] [Abstract][Full Text] [Related]
3. Subgenual Anterior Cingulate-Medial Orbitofrontal Functional Connectivity in Medication-Resistant Major Depression: A Neurobiological Marker for Accelerated Intermittent Theta Burst Stimulation Treatment?
Baeken C; Duprat R; Wu GR; De Raedt R; van Heeringen K
Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Oct; 2(7):556-565. PubMed ID: 29560909
[TBL] [Abstract][Full Text] [Related]
4. Network Mechanisms of Clinical Response to Transcranial Magnetic Stimulation in Posttraumatic Stress Disorder and Major Depressive Disorder.
Philip NS; Barredo J; van 't Wout-Frank M; Tyrka AR; Price LH; Carpenter LL
Biol Psychiatry; 2018 Feb; 83(3):263-272. PubMed ID: 28886760
[TBL] [Abstract][Full Text] [Related]
5. Neurostructural Differences in Adolescents With Treatment-Resistant Depression and Treatment Effects of Transcranial Magnetic Stimulation.
Seewoo BJ; Rodger J; Demitrack MA; Heart KL; Port JD; Strawn JR; Croarkin PE
Int J Neuropsychopharmacol; 2022 Aug; 25(8):619-630. PubMed ID: 35089358
[TBL] [Abstract][Full Text] [Related]
6. A novel concurrent TMS-fMRI method to reveal propagation patterns of prefrontal magnetic brain stimulation.
Vink JJT; Mandija S; Petrov PI; van den Berg CAT; Sommer IEC; Neggers SFW
Hum Brain Mapp; 2018 Nov; 39(11):4580-4592. PubMed ID: 30156743
[TBL] [Abstract][Full Text] [Related]
7. Functional connectivity of the left DLPFC to striatum predicts treatment response of depression to TMS.
Avissar M; Powell F; Ilieva I; Respino M; Gunning FM; Liston C; Dubin MJ
Brain Stimul; 2017; 10(5):919-925. PubMed ID: 28747260
[TBL] [Abstract][Full Text] [Related]
8. Increase of frontal cerebral blood volume during transcranial magnetic stimulation in depression is related to treatment effectiveness: A pilot study with near-infrared spectroscopy.
Shinba T; Kariya N; Matsuda S; Matsuda H; Obara Y
Psychiatry Clin Neurosci; 2018 Aug; 72(8):602-610. PubMed ID: 29774621
[TBL] [Abstract][Full Text] [Related]
9. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
10. [Repetitive transcranial magnetic stimulation in major depression: response factor].
Dumas R; Padovani R; Richieri R; Lançon C
Encephale; 2012 Sep; 38(4):360-8. PubMed ID: 22980479
[TBL] [Abstract][Full Text] [Related]
11. Baseline brain metabolism in resistant depression and response to transcranial magnetic stimulation.
Paillère Martinot ML; Martinot JL; Ringuenet D; Galinowski A; Gallarda T; Bellivier F; Lefaucheur JP; Lemaitre H; Artiges E
Neuropsychopharmacology; 2011 Dec; 36(13):2710-9. PubMed ID: 21849980
[TBL] [Abstract][Full Text] [Related]
12. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
[TBL] [Abstract][Full Text] [Related]
13. White matter integrity and functional predictors of response to repetitive transcranial magnetic stimulation for posttraumatic stress disorder and major depression.
Barredo J; Bellone JA; Edwards M; Carpenter LL; Correia S; Philip NS
Depress Anxiety; 2019 Nov; 36(11):1047-1057. PubMed ID: 31475432
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant mechanism of add-on repetitive transcranial magnetic stimulation in medication-resistant depression using cerebral glucose metabolism.
Li CT; Wang SJ; Hirvonen J; Hsieh JC; Bai YM; Hong CJ; Liou YJ; Su TP
J Affect Disord; 2010 Dec; 127(1-3):219-29. PubMed ID: 20598753
[TBL] [Abstract][Full Text] [Related]
15. Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.
Williams LM; Coman JT; Stetz PC; Walker NC; Kozel FA; George MS; Yoon J; Hack LM; Madore MR; Lim KO; Philip NS; Holtzheimer PE
BMC Psychiatry; 2021 Jan; 21(1):35. PubMed ID: 33435926
[TBL] [Abstract][Full Text] [Related]
16. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
Croarkin PE; Nakonezny PA; Wall CA; Murphy LL; Sampson SM; Frye MA; Port JD
Psychiatry Res Neuroimaging; 2016 Jan; 247():25-33. PubMed ID: 26651598
[TBL] [Abstract][Full Text] [Related]
17. Frontal-subcortical volumetric deficits in single episode, medication-naïve depressed patients and the effects of 8 weeks fluoxetine treatment: a VBM-DARTEL study.
Kong L; Wu F; Tang Y; Ren L; Kong D; Liu Y; Xu K; Wang F
PLoS One; 2014; 9(1):e79055. PubMed ID: 24427263
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic application of repetitive transcranial magnetic stimulation for major depression].
Nakamura M
Seishin Shinkeigaku Zasshi; 2012; 114(11):1231-49. PubMed ID: 23367835
[TBL] [Abstract][Full Text] [Related]
19. Gray Matter Abnormalities in Non-comorbid Medication-naive Patients with Major Depressive Disorder or Social Anxiety Disorder.
Zhao Y; Chen L; Zhang W; Xiao Y; Shah C; Zhu H; Yuan M; Sun H; Yue Q; Jia Z; Zhang W; Kuang W; Gong Q; Lui S
EBioMedicine; 2017 Jul; 21():228-235. PubMed ID: 28633986
[TBL] [Abstract][Full Text] [Related]
20. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
